
Sign up to save your podcasts
Or


We discuss the DAVIO trial of EYP-1901 with Dr. Jay S. Duker, Chief Operating Officer of Eyepoint Pharmaceuticals.
By Retina Synthesis4.5
88 ratings
We discuss the DAVIO trial of EYP-1901 with Dr. Jay S. Duker, Chief Operating Officer of Eyepoint Pharmaceuticals.

18 Listeners

2,445 Listeners

112,802 Listeners

674 Listeners

56,532 Listeners

596 Listeners

4 Listeners

11 Listeners

51 Listeners

10 Listeners

18 Listeners

2 Listeners

0 Listeners

840 Listeners